EU Puts Spotlight On $21B J&J-Synthes Merger
The European Commission said its antitrust unit would conduct an in-depth investigation into whether the planned merger would stifle competition in the orthopedic devices market.
“The proposed acquisition would remove a competitor from some markets which are already concentrated,” Commission Vice President Joaquin Almunia said. “The commission needs to make sure that effective competition is preserved,...
To view the full article, register now.